Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
RxSight, Inc. RXST
$22.54
+$0.58 (2.59%)
На 18:04, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
659068440.00000000
-
week52high
19.79
-
week52low
9.78
-
Revenue
49005000
-
P/E TTM
-7
-
Beta
0.00000000
-
EPS
-2.48000000
-
Last Dividend
0.00000000
-
Next Earnings Date
09 мая 2023 г. в 20:00
Описание компании
RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. It primarily serves cataract doctors. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Needham | Buy | Buy | 09 авг 2022 г. |
| SVB Leerink | Outperform | Outperform | 06 мая 2022 г. |
| Needham | Buy | Buy | 06 мая 2022 г. |
| Needham | Buy | 08 апр 2022 г. | |
| Wells Fargo | Overweight | 24 авг 2021 г. | |
| Wells Fargo | Equal-Weight | Overweight | 12 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Fountain Tamara | A | 23508 | 4312 | 19 янв 2023 г. |
| Fountain Tamara | A | 19196 | 19196 | 19 янв 2023 г. |
| LINK WILLIAM J PHD | A | 595409 | 107236 | 09 ноя 2022 г. |
| LINK WILLIAM J PHD | D | 258390 | 316694 | 09 ноя 2022 г. |
| LINK WILLIAM J PHD | A | 488173 | 107236 | 10 авг 2022 г. |
| LINK WILLIAM J PHD | D | 575084 | 316694 | 10 авг 2022 г. |
| LINK WILLIAM J PHD | A | 380937 | 126979 | 08 июн 2022 г. |
| LINK WILLIAM J PHD | D | 891778 | 375000 | 08 июн 2022 г. |
| Warner Robert Keith | A | 22002 | 8624 | 02 июн 2022 г. |
| Tammenoms Bakker Juliet | A | 28708 | 10349 | 02 июн 2022 г. |
Новостная лента
RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference
GlobeNewsWire
28 дек 2022 г. в 16:05
ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference.
Is RxSight (RXST) Stock Outpacing Its Medical Peers This Year?
Zacks Investment Research
06 дек 2022 г. в 11:17
Here is how RxSight, Inc. (RXST) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
RxSight, Inc. (RXST) Q3 2022 Earnings Call Transcript
Seeking Alpha
07 ноя 2022 г. в 18:28
RxSight, Inc. (NASDAQ:RXST ) Q3 2022 Results Conference Call November 7, 2022 4:30 PM ET Company Participants Alex Huang - Associate Director of Investor Relations Ron Kurtz - President and Chief Executive Officer Shelley Thunen - Chief Financial Officer Conference Call Participants David Saxon - Needham and Company Ryan Zimmerman - BTIG Operator Hello and thank you for standing by. Welcome to the RxSight Third Quarter 2022 Earnings Conference Call.
RxSight, Inc. to Report Third Quarter 2022 Financial Results on November 7, 2022
GlobeNewsWire
24 окт 2022 г. в 16:05
ALISO VIEJO, Calif., Oct. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that it will report financial results for the third quarter 2022 after the market close on Monday, November 7, 2022. The company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
RxSight, Inc. to Present at the Wells Fargo Healthcare Conference
GlobeNewsWire
24 авг 2022 г. в 16:05
ALISO VIEJO, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming Wells Fargo Healthcare Conference.